Subscribe now

Anti-cancer virus

A tumour-munching virus will be given to a large number of cancer patients for the first time. First 80, then about 200 people with head and neck tumours will get two standard anti-cancer drugs plus Reolysin, which contains a harmless reovirus. In smaller trials, this cocktail helped up to three-quarters of patients.

Credit crunch joy

Our current economic woes have one bright side. Emissions of carbon dioxide are expected to be 3 per cent lower this year than in 2008 due to the economic slowdown, according to the International Energy Agency.This is the steepest drop in 40 years.…

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers

Popular articles

Trending New Scientist articles

Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop